Barclays Maintains an 'Underweight' on Arena Pharma (ARNA); Reports 4Q, Uncertainty Persists

Go back to Barclays Maintains an 'Underweight' on Arena Pharma (ARNA); Reports 4Q, Uncertainty Persists